UnitedHealth Group Incorporated (UNH)
UnitedHealth Group (UNH) Expected to Beat Earnings Estimates: Should You Buy?
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Outperforms Broader Market: What You Need to Know
UnitedHealth Group (UNH) closed the most recent trading day at $313, moving +2.85% from the previous trading session.
UnitedHealth: Trust Is Broken - But The Model Isn't
UnitedHealth faces a temporary margin reset, not a structural impairment, following margin pressure and guidance withdrawal. Current valuation (~17x NTM P/E) reflects uncertainty, but even partial margin normalization could drive a re-rating. Premium increases and membership adjustments are restoring insurance profitability, with Optum Health shifting focus from growth to execution.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's how Warren Buffett is doing on his UnitedHealth stock investment
Despite making his investment during the UnitedHealth (NYSE: UNH) stock market bloodbath of the second quarter (Q2) of 2025, Warren Buffett was down an estimated $265 million on the bet as recently as late March.
UnitedHealth (UNH) Soars 9.4%: Is Further Upside Left in the Stock?
UnitedHealth (UNH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Buy UnitedHealth or Humana Stock as Medicare Advantage Rates Increase?
A much larger-than-expected increase in Medicare Advantage payment rates triggered a broad relief rally across health insurer stocks on Monday, with UnitedHealth and Humana leading the way.
Health Insurance Stocks Are Soaring on a Medicare Update. Here's What You Need to Know.
Health insurer stocks are surging after a bigger-than-expected boost to Medicare Advantage payment rates.
UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears
UnitedHealth Group (NYSE:UNH) stock is up nearly 11% today, moving from $281.36 to $311 and change, as the managed care sector stages a powerful relief rally.
UnitedHealth: Quantifying The Impact Of The New CMS Payment Increase
UnitedHealth Group faces profitability challenges amid elevated utilization and significant Medicare Advantage member losses, prompting a 2% YoY revenue decline forecast for 2025. I believe the 2.48% CMS MA rate increase for 2027 will translate to ~$3.94 billion in incremental revenue. UNH can leverage the CMS windfall to enhance supplemental benefits, bid more aggressively, and potentially resume market expansion and buybacks as its debt-to-capital ratio improves.
UnitedHealth Jumps on CMS' MA Rate Boost: How to Position Now
CMS boosts 2027 Medicare Advantage rates, sparking a sharp UNH rally despite lingering cost pressures.
Wall Street sets UnitedHealth stock price target
UnitedHealth (NYSE: UNH) was in the spotlight on Tuesday, April 7, soaring more than 8% following a new payment update from the Centers for Medicare & Medicaid Services.
